Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Trial of Enbrel in Patients With Primary Systemic Amyloidosis

NCT00224393 is registered in ClinicalTrials.gov with The Cleveland Clinic as lead sponsor.

NCT NCT00224393
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00224393 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Trial of Enbrel in Patients With Primary Systemic Amyloidosis
Lead sponsor
The Cleveland Clinic
Phase
Phase 2
Overall status
Completed
Start date
February 28, 2001
Completion date
August 31, 2005
Enrollment
60
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

primary systemic amyloidosis